| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.137 | 7.710 | 5.842 | 6.476 | 5.942 | 6.726 | 5.759 |
| Total Income - EUR | - | - | - | 7.137 | 7.710 | 5.842 | 6.476 | 5.942 | 6.726 | 5.759 |
| Total Expenses - EUR | - | - | - | 1.033 | 1.361 | 4.603 | 5.876 | 6.418 | 5.627 | 5.616 |
| Gross Profit/Loss - EUR | - | - | - | 6.103 | 6.350 | 1.239 | 600 | -477 | 1.099 | 143 |
| Net Profit/Loss - EUR | - | - | - | 5.889 | 6.118 | 1.078 | 421 | -651 | 837 | 41 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Psycons Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 716 | 2.666 | 2.139 | 2.223 | 3.181 | 2.168 |
| Current Assets | - | - | - | 6.009 | 11.219 | 10.370 | 10.797 | 6.203 | 5.994 | 6.040 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 140 | 232 |
| Receivables | - | - | - | 0 | 0 | 0 | 648 | 1.637 | 1.670 | -484 |
| Cash | - | - | - | 6.009 | 11.219 | 10.370 | 10.149 | 4.566 | 4.183 | 6.293 |
| Shareholders Funds | - | - | - | 5.932 | 11.936 | 12.788 | 12.926 | 8.259 | 9.070 | 8.205 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 76 | 0 | 247 | 10 | 168 | 104 | 3 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Psycons Med S.r.l.